American company Abbott announced in a press release on Saturday that it is restarting a large Michigan-based (north) factory, whose closure for several months was caused by a lack of infant formula affecting all of the United States.
Abbott specified that the factory, after fulfilling the conditions set by the American Medicines Agency (FDA), will specifically begin selling one of its products, EleCare hypoallergenic milk, from around June 20.
This said the manufacturer, which controls 40% of the infant formula market in the United States Worked well to relaunch production of another brand that is very popular with American families, Similac, as well as its other ranges.
We understand the immediate need for infant formula and our first priority is to get safe, high -quality milk to families across the United States.we read in its press release.
Serious hygiene issues
The world’s leading power has been experiencing infant formula supply problems for some time, linked to the COVID-19 pandemic, when Abbott announced in February the recall of products suspected of causing the deaths of two babies, as well as closing them. factories, which caused severe shortages.
The group has already apologized at a congressional hearing. The FDA a, he describes the serious health problems in the factory concerned.
Honestly, the results of the (site) inspection are surprisingtestified to Robert Califf, the boss of this agency, at this hearing on May 25.
To address the shortage, the Biden administration, accused of the latter reacting, has set up a type of airlift to carry, via military planes, tons of overseas-made infant formula.
Source: Radio-Canada
